Skip to main content

John Schreiber, MD

Languages:
English
Service: Neurology
Specialty/Profession:
Pediatric Neurology
Board Certifications:
American Board of Psychiatry & Neurology – Neurology with Special Qualification in Child Neurology; Subspecialty certification in Clinical Neurophysiology and Epilepsy
Areas of Clinical Interest:
Epilepsy, neurogenetics, electroencephalography
Education:

Fellowship: National Institutes of Health (2013)
Residency: Children's National Medical Center (2011)
Medical School: University of Maryland School of Medicine (2006)
Undergraduate: Franklin & Marshall College (2001)

Awards & Recognition:

Fellow of the American Epilepsy Society (2020-current) 

Top Doctors Recognition: Arlington Magazine, Northern Virginia Magazine 
 
Rare Diseases Clinical Research Network (RDCRN) Certificate Program Scholar (2018-2019); early career investigators must apply and be selected for participation in this one-year, RDCRN R25-supported program designed to promote research in rare diseases 

Epilepsy Foundation SUDEP Challenge Award (2017) awarded for our work in speckle tracking echocardiography 

"The Cute Syndrome Foundation" Clinician Award (2017) given to an outstanding clinician in SCN8A-related epilepsy 

Tell Me Town Foundation Traumatic Brain Injury Education Award (2017) 

J. Kiffin Penry Epilepsy Mini-Fellowship Travel/ Attendance Scholarship (2011) awarded to select Child Neurology Fellows 

Pediatric Residency Teaching Award (2006-2007 and 2007-2008) 

University of Maryland School of Medicine Cum Laude (2006) 

University of Maryland School of Medicine Marshall L. Rennels Award for Excellence in Neuroscience (2006) 

Alpha Omega Alpha Medical Honor Society Member (2005-2006) 

University of Maryland School of Medicine Humanism Honor Society Member (2005-2006) 

Clinic Locations: Fairfax

Keystone Publications:

Schreiber J, Chapman KA, Summar ML, Mew NA, Sutton VR, Macleod E, Stagni K, Ueda K, Franks J, Island E, Matern D, Peña L, Smith B, Urv T, Venditt C, Chakarapani A, Gropman AL.  Neurologic considerations in propionic acidemia.  Mol Gen Metab 2011; 105(1): 10-15.

Schreiber JM, Zelleke T, Gaillard WD, Kaulas H, Dean N, Carpenter JL.  Continuous video EEG for patients with acute encephalopathy in a pediatric intensive care unit.  Neurocrit Care 2012; 17(1): 31-38.

Pierson TM, Yuan H, Marsh ED, Fuentes-Fajardo K, Adams DR, Markello T, Golas G, Simeonov DR, Holloman C, Tankovic A, Karamchandani MM, Schreiber JM, Mullikin JC; PhD for the NISC Comparative Sequencing Program, Tifft CJ, Toro C, Boerkoel CF, Traynelis SF, Gahl WA.  GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.  Ann Clin Transl Neurol 2014; 1: 190-198.

Schreiber JM, Lanham DC, Trescher WH, Sparks SE, Wassif CA, Caffo BS, Porter FD, Tierney E, Gropman AL, Ewen JB.  Variations in EEG discharges predict ADHD severity within individual Smith-Lemli-Opitz patients.  Neurology 2014; 83: 151-159.

Pearl P, Schreiber J, Theodore W, McCarter R, Barrios E, Yu J, Wiggs E, He J, Gibson M.  Taurine trial in succinic semialdehyde sehydrogenase (SSADH) deficiency and elevated CNS GABA.  Neurology 2014; 82: 940-944.

Schreiber JM, Tochen L, Brown M, Evans S, Ball LJ, Bumbut A, Thewamit R, Whitehead MT, Black C, Boutzoukas E, Fanto E, Suslovic W, Berl M, Hammer M, Gaillard WD. A multi-disciplinary clinic for SCN8A-related epilepsy. Epilepsy Res 2020;159:106261. PMID: 31887642 

Schreiber JM, Frank L, Kroner BL; Bumbut A, Ismail MO, Gaillard WD. Children with Refractory Epilepsy Demonstrate Alterations in Myocardial Strain. Epilepsia  2020; 61:2234-2243. PMID: 33053223  
 
Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH. A Randomized Controlled Trial of SGS742, a GABA-B Receptor Antagonist, for SSADH Deficiency. J Child Neurol. Epub 2021 May 20. PMID: 34015244. 
 
Kramer ZJ, Brandt C, Havens K, Pasupuleti A, Gaillard WD, Schreiber JM. Telehealth for patients with rare epilepsies. Ther Adv Rare Dis. 2022; 3:1-11. https://doi.org/10.1177/26330040221076861 

Patient Reviews:
"Everyone from check in to check out was very professional and helpful. Dr. Schreiber is one of the best. We travel all the way from the Philadelphia area to see him. Thank you!"

"Dr. Schreiber is a very caring individual who listens to your concerns, examines the patient, develops effective solutions, works well with his team, and is extremely knowledgeable in his area of expertise."

"Dr. Schreiber is excellent in every way." 

Service: Neurology
Where did you grow up?
Westminster, MD
Why did you become a doctor and why did you choose your specialty?
I enjoy working with people and have always been fascinated by the brain. As a child neurologist, I have the unique opportunity to intervene at a critical stage in a child’s development to provide treatment and improve the quality of life for patients and families coping with neurological disease.
How long have you practiced in the Washington, DC area and what do you like most about it?
I have practiced in the Washington, DC area since starting residency in 2006. I enjoy the diversity of patients, the proximity to the nation’s capital, and the vibrant scientific research community.
What do you most enjoy doing outside of your clinical practice, when you’re not working?
Spending time with family and friends, running, and singing.
Do you volunteer? If so, where?
Clinical Advisory Board for COMBINEDBrain (2021-current)
Einstein Visiting Fellowship Reviewer (2021)
American Academy of Neurology Susan Spencer Research Award Reviewer (2021-2022)
Professional Advisory Board for the Epilepsy Foundation (2020-current)
American Epilepsy Society Investigators’ Workshop Selection Committee (2019-current; Vice Chair 2022-2023)
Pediatric Epilepsy Research Consortium Genetics Working Group (2019-2021 member; 2022-2023 lead)
The Cute Syndrome Foundation (TCSF) Research Roundtable. Chair, “Planning a Natural History: What questions should a natural history answer?” Chapel Hill, NC (July 10, 2019)
NIH NINDS ZNS1 SRB-A(26) Special Emphasis Panel Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (PAR-18-534) (June 2019)
Scientific Advisory Board for the Bow Foundation (2017-current)
Medical Advisory Board for the Mowat Wilson Syndrome Foundation (2017-current)
Scientific Advisory Board for The Cute Syndrome Foundation (2017-current)
Scientific Advisory Board for Wishes For Elliott (2016-2017)
Physician Advisory Board for Brainy Camps Association, a subsidiary of Children's National Health System (2016-current)
Scientific Advisory Board for Succinic Semialdehyde Dehydrogenase Deficiency Foundation (2015-current)
Personal Sketch:

4 - Children